Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ATS Becomes Accuratus Lab Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

ATS Becomes Accuratus Lab Services

Hess and Roth take on additional executive roles

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ATS Labs is changing its name to Accuratus Lab Services following the recently completed acquisition of Microtest Labs of Agawam, MA, expanding its service offering into the medical device and pharmaceutical segments. 
 
Executive chairman Tom Burnell said, “The new identity and logo had to satisfy all of the existing expectations and strengths associated with the historical ATS Labs and Microtest Laboratories businesses while simultaneously personifying the scientific experience, quality solutions and accurate test results the combined companies provide to the growing medical device, biopharmaceutical and antimicrobial industries.” 
 
Eric Hess was appointed chief executive officer of Accuratus Lab Services in October 2014. Mr. Hess will directly lead the sales and marketing initiatives, also serving as the company’s chief business officer. Alan Roth, who has been serving as the company’s chief financial officer, will now also serve as the chief operating officer. In addition to the accounting and finance functions, he will assume direct responsibility for operations, facilities, IT and risk management.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics